Negative selection of peripheral blood stem cells to support a tandem autologous transplantation programme in multiple myeloma
Autor: | Anna Maria, Barbui, Monica, Galli, Gianpietro, Dotti, Nadia, Belli, Gianmaria, Borleri, Giovanna, Gritti, Piermario, Bellavita, Piera, Viero, Benedetto, Comotti, Tiziano, Barbui, Alessandro, Rambaldi |
---|---|
Rok vydání: | 2002 |
Předmět: |
Adult
Male Neoplasm Residual Hematopoietic Stem Cell Transplantation Middle Aged Neoplastic Cells Circulating Polymerase Chain Reaction Transplantation Autologous Disease-Free Survival Survival Rate Leukocyte Count Blood Component Removal Humans Female Prospective Studies Multiple Myeloma Aged Follow-Up Studies |
Zdroj: | British journal of haematology. 116(1) |
ISSN: | 0007-1048 |
Popis: | We recently described a two-step negative selection procedure whereby peripheral blood stem cells (PBSCs) were efficiently purged of contaminating neoplastic cells by a combination of monoclonal antibodies. Here, we report 60 newly diagnosed multiple myeloma (MM) patients treated with a double transplant programme and randomized to receive either unmanipulated or in vitro purged PBSCs. We demonstrated that this technique is feasible and safe without significant loss of either CD34+ or CD3+ cells. Haematological engraftment and immunological reconstitution were rapid without treatment-related mortality. Using polymerase chain reaction (PCR), we compared the level of minimal residual disease (MRD) in PBSC before and after in vitro purging and in vivo after transplant. A median of one tumour cell per 10(2) normal cells (range 10(1)-10(5)) was seen in the unmanipulated aphereses with a 3-4 log reduction after manipulation in vitro. However, despite this tumour debulking, all patients remained PCR positive in vivo. At 3 years, the estimated event-free survival was 40% in the control arm and 72% in the experimental arm (P = 0.05), whereas the estimated overall survival was 83% in both arms. This suggests that autologous transplantation using efficiently purged PBSCs can be performed safely, but confirms the need for innovative protocols for MRD eradication in vivo. |
Databáze: | OpenAIRE |
Externí odkaz: |